The global proteomics market, valued at USD 35.7 billion in 2025, is projected to reach USD 40.2 billion in 2026 and USD 94.7 billion by 2035, with a 10.0% CAGR during the forecast period 2026 to 2035. In terms of type of offering, the kits and reagents segment holds the highest share (75%) of the market. With regards to type of instrument / technology, the spectrometry segment dominates the global market with close to 30% market share. In terms of types of proteomics service, the core proteo...

The global aseptic filling machine market size, valued at USD 1,531 million in 2025, is projected to reach USD 1,703 million in 2026 and USD 3,432 million by 2035, representing a CAGR of 8.1% during the forecast period. Over the past couple of decades, pharma equipment manufacturers have developed more efficient, reliable and cost-effective machinery, involving the required isolators and restricted access barrier systems (RABS), to their proprietary aseptic fill finish lines. Many such systems a...

The global flow cytometry market size is valued at USD 5.1 billion in 2024 and is poised to reach USD 10.75 billion in 2032, representing a CAGR of 8.25% during the forecast period. Based on the type of product, the market for flow cytometry is split into reagents and consumables, flow cytometry instruments, accessories, flow cytometry services, and software. Reagents and consumables are expected to dominate the segment with more than 54% of the total flow cytometry market share in 2024. The adv...

The global bioprocess containers market size is estimated to grow from USD 4.73 billion in 2025 to USD 32.10 billion by 2035, representing a compounded annual growth rate (CAGR) of 21.1% during the forecast period. It is important to highlight here that in April 2022, Thermo Fisher Scientific opened its 55,000 sq. feet single-use technology facility in Ogden which is dedicated to single-use bioprocess containers. This single-use technology facility in Ogden is worth USD 44 million and is a part...

The global DNA read, write and edit market is expected to increase from USD 8.33 billion in 2025 to USD 29.78 billion by 2035, representing a CAGR of 13.6% during the forecast period. Presently, the key players of the industry are focusing on the development of next generation genome sequencing technologies that aid in editing genes precisely with higher accuracy rate. For instance, in October 2024, Illumina launched the MiSeq

The multiomics market size is projected to grow from USD 3.10 billion in 2025 to USD 12.65 billion by 2035, representing a CAGR of 15.09% during the forecast period till 2035. Biomedical firms and emerging drug discovery companies are investing in the industry to leverage the technology. For instance, in May 2024, MultiOmic Health raised $6.2 million in a seed funding extension to develop its precision therapeutic platform for metabolic syndrome-related conditions. The funding was led by Hoxton...

The bioreactors market size is estimated to grow from $16.7 billion currently to $51.7 billion by 2035, representing a CAGR of 11.1% during the forecast period, till 2035. The global expansion of biopharmaceutical products has led to significant growth in the bioprocessing supplies market. Over the past two decades, this market has consistently grown at an annual rate of between 12 and 14%. With companies either establishing their own biopharmaceutical manufacturing facilities or outsourcing pro...

The global cold chain market for pharmaceuticals, valued at USD 6.6 billion in 2025, is projected to reach USD 6.9 billion in 2026 and USD 9.6 billion by 2035, with a 3.8% CAGR during the forecast period, 2026 to 2035. The pharma cold chain specifically addresses the requirements of freezing / cryogenic holding temperature for a wide variety of temperature sensitive pharmaceutical products, such as biologics, covid vaccines, human organs, and certain conventional pharmacological interventions, s...

Viral sensitizers market, a notable segment of the viral manufacturing consumables market, is anticipated to grow at a compounded annual growth rate (CAGR) of 14% during the forecast period. Over the last two decades, the gene therapy industry has witnessed several breakthroughs including the FDA approval of Abecma for the treatment of adult patients with relapsed or refractory multiple myeloma and the commercialization approval of Libmeldy

Botanicals, also known as botanical medicines, are plant-derived substances valued for their medicinal or therapeutic properties, flavor, and scent. The botanicals market presents significant opportunities driven by increasing consumer preference for natural and organic products, rising awareness of the health benefits of botanicals, and their diverse applications in food and beverage, dietary supplements, personal care products, and cosmetics. Based on applications, the botanicals market is ana...

The global total lab automation market, valued at USD 670 million in 2025, is projected to reach USD 746 million in 2026 and USD 2,502 million by 2035, with a 14.4% CAGR during the forecast period 2026 to 2035. Total lab automation is an advanced approach that aims to streamline and optimize laboratory processes by integrating various instruments, devices and software into a unified system. Presently, more than 45 total lab automation companies are engaged in offering various automated instr...

The global fermenters and bioreactors market is estimated to grow from USD 25.9 billion in 2025 to reach USD 29.1 billion in 2026 and USD 73.7 billion by 2035, representing a higher CAGR of 10.9% during the forecast period. In fact, in the past two decades, over 170 biopharmaceuticals have already been granted approval by the FDA and over 7,500 biological interventions are under evaluation in clinical trials. It is a well-known fact that the commercial and clinical scale manufacturing of such co...

The single use bioprocessing market, valued at USD 5.1 billion in 2025, is projected to grow to USD 5.8 billion in 2026 and USD 15.5 billion by 2035, representing a CAGR of 11.5% during the forecast period. Several single-use bioprocessing companies are engaged in developing and manufacturing single-use upstream bioprocessing technologies and equipment, such as single use bioreactors, single use mixers, single-use filters, single-use media bags and containers, single-use sampling systems and sin...

The global cell therapy media market, valued at USD 1.6 billion in 2025, is projected to reach USD 1.8 billion in 2026 and USD 4.5 billion by 2035, with a 10.6% CAGR during the forecast period 2026 to 2035. The cell therapy consumable providers market landscape features more than 80 companies, which claim to possess the necessary expertise for manufacturing of over 450 research and / or therapeutic grade raw materials. Further, it is worth highlighting that more than USD 35 billion has already i...

The global single use sensors market size, valued at USD 0.50 billion in 2025, is projected to reach USD 0.58 billion in 2026 and USD 1.92 billion by 2035, representing a CAGR of 14.2% during the forecast period. The biopharmaceutical industry is witnessing an upsurge due to the growing demand for advanced therapeutic drugs that target a broad range of diseases. Several blockbuster drugs, including monoclonal antibodies and cell and gene therapies, require highly controlled bioprocessing technol...

The global cell migration and cell invasion assay market, valued at USD 1.6 billion in 2025, is projected to reach USD 1.8 billion in 2026 and USD 3.5 billion by 2035, representing a CAGR of 7.7% during the forecast period. Given their extensive utilization in various drug discovery, tumor study and screening applications, there has been a significant rise in the revenue generation potential associated with cell migration and cell invasion assay kits. The current cell migration and cell invasion...

The pharmaceutical secondary packaging market, valued at $ 7.6 billion in 2025, is projected to grow to $ 8.2 billion in 2026 and $ 16.1 billion by 2035, representing a CAGR of 7.8% during the forecast period. Pharmaceutical secondary packaging is a vital step in the product supply chain as it encloses life-saving drugs and therapies, preserving the identity, quality, integrity and stability of the packaged drug product. It also plays a key role in marketing and brand projection for a product. H...

The viral vaccine cell culture media market, valued at USD 2.5 billion in 2025, is projected to grow to USD 2.7 billion in 2026 and USD 3.4 billion by 2035, representing a CAGR of 2.6% during the forecast period. Over the past few years, a number of advanced vaccines targeting a myriad of disease indications have received approval from various regulatory authorities. Post the onset of COVID-19, there has been a surge in the demand for viral vaccines. In fact, it is estimated that more than 4.5 b...

The global NGS kits market, valued at USD 2.1 billion in 2025, is projected to reach USD 2.5 billion in 2026 and USD 11.5 billion by 2035, with a 18.3% CAGR during the forecast period 2026 to 2035. Given the ongoing innovation in NGS testing kit and next generation sequencing kits market, stakeholders further believe that, over the next decade, the aforementioned cost may further get reduced to USD 100. It is worth mentioning that this decrease in genome sequencing cost has led to an increase...

The global bioprocess automation market is estimated to grow from USD 6.5 billion in 2025 to reach USD 10.6 billion by 2030, representing a higher CAGR of 10.0% during the forecast period. Given the various advantages of controllers and automated systems, biopharmaceutical developers and manufacturers are steadily adopting such solutions. Moreover, the recent surge in demand for vaccines amidst the ongoing COVID-19 pandemic has also prompted the biopharmaceutical companies to develop automation...